Siga Technologies INC Deferred Tax Assets, Deferred Income
Siga Technologies INC (SIGA) had Deferred Tax Assets, Deferred Income of $2.31 million as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2026-03-10
- 2025-12-31: Deferred Tax Assets, Deferred Income $2.31M.
- 2024-12-31: Deferred Tax Assets, Deferred Income $2.23M.
- 2023-12-31: Deferred Tax Assets, Deferred Income $2.26M.
- 2022-12-31: Deferred Tax Assets, Deferred Income $66.01K.
| Period end | Deferred Tax Assets, Deferred Income |
|---|---|
| 2025-12-31 | $2.31M 10-K · filed 2026-03-10 |
| 2024-12-31 | $2.23M 10-K · filed 2026-03-10 |
| 2023-12-31 | $2.26M 10-K · filed 2025-03-11 |
| 2022-12-31 | $66.01K 10-K · filed 2024-03-12 |
| 2021-12-31 | $702.62K 10-K · filed 2023-03-02 |
| 2020-12-31 | $709.48K 10-K · filed 2022-03-03 |
| 2019-12-31 | $719.30K 10-K · filed 2021-03-04 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-05 |
| 2017-12-31 | $84.13M 10-K · filed 2019-03-06 |
| 2016-12-31 | $102.52M 10-K · filed 2018-03-06 |
| 2015-12-31 | $59.89M 10-K · filed 2017-03-07 |
| 2014-12-31 | $37.91M 10-K · filed 2016-03-04 |
| 2013-12-31 | $48.69M 10-K · filed 2015-03-06 |
| 2012-12-31 | $4.40M 10-K · filed 2014-03-10 |
| 2011-12-31 | $0.00 10-K/A · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |